Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. — St Louis, Missouri

Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Hematologic Neoplasms.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr.?

Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. conducted?

Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. has 1 clinical trials on record. Their work covers Breast Cancer, Hematologic Neoplasms.

Is Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. accredited by Crixeo Health?

Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.